Claims Against Clinical Research Defendants Dismissed in Raptiva Case



DOCUMENTS
  • Order


DALLAS - A Texas federal judge has refused to remand to state court a Raptiva injury suit, ruling that the non-diverse clinical research defendants were improperly joined because the claims against them fail as a matter of law. McCall v. Genentech Inc., et al., No. 10-1747-B (N.D. Texas).

On June 9, Judge Jane J. Boyle of the U.S. District Court for the Northern District of Texas ruled that the plaintiff's negligence claims against a clinical researcher fail because the researcher owed no duty to the plaintiff under Texas law.

Mabel McCall alleges that Dr. Alan Menter prescribed Raptiva to treat …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's New Jersey Asbestos Litigation Conference

February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS